Get the presentations from the selected finalists and applause the winners
Nordic Life Science Awards
This year we inaugurate the new Nordic Life Science Awards competition.
The Nordic Life Science Awards will be given to one academic research group project (“Academic Class”) with a break-through potential and to one life science-company (“Business Class”) considered by the jury to best meet the award criteria presented in this document. A second company (“Delegates Choice”) will be selected by popular vote.
The Jury consists of:
- Dr. Sara Gunnerås, Director Business & Finance, SwedenBIO (Chair)
- Dr. Ulrica Sehlstedt, Partner, Arthur D. Little
- Ms. Sophie Labrosse, Cluster Officer at Novo Nordisk Foundation
- Dr. Christos Vaitsis, Business Creation Manager at EIT Health Scandinavia
- Ms. Erna Björnsdóttir, Manager, Invest in Iceland at Promote Iceland
Part 1 – Nordic Life Science Academic Class Award
| “Advancing academic ideas into innovations for patients”
Academia is a key engine for medical innovation and many life science projects becoming commercial successful originate from academic centers. Big ideas very often come from ground-braking academic research. Recognizing that the majority of the global companies made academic-industrial partnerships an integral part of their strategies and opened their R&D organizations to external innovation.
The Academic Catwalk features exciting academic projects from five Nordic countries illustrating the rich and broad research milieus and their motivation to advance their ideas into innovations for patients. The session is hosted by SPARK Norway and delivered in collaboration with SPARK Finland, the Swedish SciLifeLabs, the Danish BioInnovation Institute, Promote Iceland and sponsored by Arthur D. Little and EIT Health Scandinavia.
| SciLifeLab Sweden
| SPARK Norway, UiO:Life Science at the University of Oslo
| SPARK Finland
| BioInnovation Institute Denmark
Part 2 – Nordic Life Science Business Class and Delegates Choice Awards
Nordic life science companies are well known and respected for their strong science-base and a long history of bringing innovation to the market. The company session will feature two companies from each of the Nordic countries. The winner of the “Business Class Award” show scientific excellence and run projects that have a break-through possibility or have already made it to the market adding significant value to patients. For the “Delegates Choice Award”: the audience will be asked to vote for the company they are most likely to invest in should they be given the opportunity. The session is hosted by SwedenBIO, Oslo Cancer Cluster, Turku Science Park, the Danish BioInnovation Institute and sponsored by Arthur D. Little and EIT Health Scandinavia.
Ms. Sarah Lidé, Senior strategy and project manager, Medicon Valley Alliance
Akthelia (Iceland) A novel antimicrobial platform
Cirqle (Denmark) Focused on developing innovative contraceptives
Delsitech (Finland) New nanotech solutions in drug delivery
Elypta (Sweden) Metabolic biomarkers and AI to detect cancer
EpiEndo (Iceland) Focused on novel solutions for chronic airway diseases
Saromics (Sweden) Protein crystallography and drug discovery services
Synklino (Denmark) Eradicating cytomegalovirus infections
UiO: University of Oslo
Oslo Cancer Cluster
The Life Science Cluster
Arthur D. Little